Le Lézard
Classified in: Science and technology
Subjects: SVY, MRR

AI Chipset Shipments Reach 1.3 Billion in 2030, Bringing On-Device AI to Smartphones, PCs, Tablets, and Gaming Consoles


NEW YORK, May 7, 2024 /PRNewswire/ -- Smartphone and PC vendors have shifted focus to on-device generative Artificial Intelligence (AI). They have committed significant resources to producing chipsets that can handle inference workloads previously limited to the cloud. According to global technology intelligence firm ABI Research, this will unlock AI chipset shipments and revenue growth in these industries and extend to tablets and gaming consoles, reaching over 1.3 billion shipments in 2030.

2024 Logo

"In the smartphone market, OEMs like Vivo and Samsung have started implementing heterogenous AI chipsets and investing in generative AI applications to deploy on their devices. While chip vendors Qualcomm and MediaTek have promoted their developer and optimization tools to kickstart application development," explains Paul Schell, Industry Analyst at ABI Research. The same applies to the PC market, where chip vendors like AMD and Intel have started shipping heterogenous AI chipsets for PCs, complemented by the concerted effort between OEMs and ISVs like Microsoft to build optimized AI software. "We can observe all corners of the ecosystem rallying behind the potential of low-latency, data-private AI applications that can scale beyond cloud environments, although we are still at a very early stage."

Heterogenous AI chipsets capable of distributing workloads between CPU, GPU, and NPU are highly effective architectures for tackling today's diverse AI workloads ? including generative and multimodal AI ? and these systems will be adopted across device markets at an accelerating rate. More demanding on-device AI workloads in PCs will be addressed by GPU cards, like NVIDIA's RTX, and AMD's high-end Radeon hardware. This is why these chipsets, which reside outside of heterogenous systems, will remain in the AI mix going forward.

For on-device AI in personal and work devices to fulfill its potential, application development incentives like Intel's AI PC Acceleration Program and the in-house work from captive vendors Apple and Google will need to bear fruit to convince consumer and enterprise customers to pay a premium. "ABI Research believes productivity AI applications can reduce refresh cycles of smartphones, notebooks, and desktops ? as well as other AI applications in tablets and gaming consoles ? and provide the incentive to bring about this uptick in demand," Schell concludes.

These findings are from ABI Research's Artificial Intelligence and Machine Learning: Personal & Work Devices market data report. This report is part of the company's AI & Machine Learning research service, which includes research, data, and ABI Insights.

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research????????????????????????????????????????????????????????????????????????????????????????????????????

For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info:

Global
Deborah Petrara
Tel: +1.516.624.2558
[email protected]  

Logo - https://mma.prnewswire.com/media/2309035/ABI_Research_2024.jpg


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform today announced it has joined Mastercard Priceless Planet Coalition in support of fighting climate change through funding the restoration of 100 million trees. This announcement...

at 20:00
The advanced laser and plasma solution provider from Taiwan, E&R Engineering Corp., is confirmed to attend the feast in Semiconductor industry, Semicon SEA 2024, held in Kuala Lumpur, Malaysia. With the 30-year dedication in the semiconductor...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: